H2020-JTI-IMI2-2017-11-single-stage

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• EUROPEAN PATIENTS FORUM1 coordinated
• MHRA1 coordinated
• UMC UTRECHT1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• ABBVIE INC2 projects · US
• BAYER AKTIENGESELLSCHAFT2 projects · DE
• GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED2 projects · UK
• NOVARTIS2 projects · CH
• PFIZER2 projects · UK
• UCB2 projects · BE
• EUROPEAN PATIENTS FORUM1 projects · BE
• MHRA1 projects · UK
• UMC UTRECHT1 projects · NL
• UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• ABBVIE INC2 projects · company
• BAYER AKTIENGESELLSCHAFT2 projects · company
• GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED2 projects · company
• NOVARTIS2 projects · company
• PFIZER2 projects · company
• UCB2 projects · company
• AMGEN LIMITED1 projects · company
• YAMANOUCHI EUROPE BROCADES PHARMA1 projects · company
• ASTRAZENECA AB1 projects · company
• CSL BEHRING GMBH1 projects · company
• ELI LILLY AND COMPANY LTD1 projects · company
• LASER1 projects · sme

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 12 · avg 13.67

range 12 – 17 organisations

Country spread (sample)

12 countries

10–14 partner organisations (from median 12.0 in this call’s projects) · 12 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• GetReal Initiative€1,750,000
• WEB-RADR 2€1,168,750
• EFOEUPATI€365,243